ISSN: 0163-7258

Journal Home

Journal Guideline

Pharmacology and Therapeutics Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 211. It has an SJR impact factor of 3.085 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3.085.

Pharmacology and Therapeutics focuses its scope in these topics and keywords: therapeutic, cancer, drug, actions, biology, pharmacology, molecular, diseasethe, garlictargeting, diseases, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3.085

SJR Impact factor

211

H Index

185

Total Docs (Last Year)

460

Total Docs (3 years)

40141

Total Refs

6443

Total Cites (3 years)

460

Citable Docs (3 years)

12.95

Cites/Doc (2 years)

216.98

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Annual Review of Pharmacology and Toxicology Q1
Perspectives in Medicinal Chemistry Q1
Drug Resistance Updates Q1
Trends in Pharmacological Sciences Q1

Compare this journals

Aims and Scope

Best articles by citations

Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

PHARMACOLOGY & THERAPEUTICS

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine

The regulation of nerve growth factor synthesis and delivery to peripheral neurons

Market structure and conduct in the pharmaceutical industry

The use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future

Ethanol regulation of gamma-aminobutyric acidA receptors: genomic and nongenomic mechanisms

Potassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases

Modification of alternative splicing pathways as a potential approach to chemotherapy

Drug targeting via retrometabolic approaches

Clinical benefits and pharmacology of scutellarin: A comprehensive review

SHOW MORE ARTICLES

Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?

Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones

Structure-activity relationships among guanine-quadruplex telomerase inhibitors

Antimalarial activity of synthetic analogues of distamycin

Preface

The dynamics of drug resistance in Plasmodium falciparum

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions

Selective activation of E-type prostanoid3-receptors reduces myocardial infarct size

Antitoxic immunity in cholera and enterotoxigenic escherichia coli (ETEC) diarrhea

Adverse effects of established and new antiepileptic drugs: An attempted comparison

Methyltransferase pharmacogenetics

The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention